UK Mutation Detection Kits In Genome Editing Market Size & Outlook

The mutation detection kits in genome editing market in UK is expected to reach a projected revenue of US$ 11,325.2 million by 2028. A compound annual growth rate of 16.4% is expected of UK mutation detection kits in genome editing market from 2021 to 2028.

Revenue, 2020 (US$M)
$3,357.4
Forecast, 2028 (US$M)
$11,325.2
CAGR, 2021 - 2028
16.4%
Report Coverage
UK

UK mutation detection kits in genome editing market highlights

  • The UK mutation detection kits in genome editing market generated a revenue of USD 3,357.4 million in 2020 and is expected to reach USD 11,325.2 million by 2028.
  • The UK market is expected to grow at a CAGR of 16.4% from 2021 to 2028.
  • In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2020.
  • (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.


Mutation detection kits in genome editing market data book summary

Market revenue in 2020USD 3,357.4 million
Market revenue in 2028USD 11,325.2 million
Growth rate16.4% (CAGR from 2020 to 2028)
Largest segment(crispr)/cas9
Fastest growing segment(CRISPR)/Cas9
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentation(CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease
Key market players worldwideThermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC


Other key industry trends

  • In terms of revenue, UK accounted for 2.6% of the global mutation detection kits in genome editing market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Europe, Germany mutation detection kits in genome editing market is projected to lead the regional market in terms of revenue in 2028.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 16,679.0 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mutation Detection Kits In Genome Editing Market Scope

Mutation detection kits in genome editing market segmentation & scope
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
ZFN
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Others
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations

Mutation Detection Kits In Genome Editing Market Companies

Name Profile # Employees HQ Website

UK mutation detection kits in genome editing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.


(crispr)/cas9 was the largest segment with a revenue share of 42.7% in 2020. Horizon Databook has segmented the UK mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.


The significant growth rate of this country’s market can be attributed to permissions granted by regulatory agencies for application of gene editing technologies on human embryos. The Human Fertilization and Embryology Authority (HFEA) approved a license to a scientist at Francis Crick institute, London, to perform gene editing on human embryos to attain better understanding of early embryonic development.

In 2016, the UK became the first country to allow genetic modifications in embryo stage, along with being the first country to permit legal replacement of an embryo with a third person’s genes. Thus, rapid adoption of geneediting technology for stem cell research, regenerative therapy, and drug discovery are anticipated to boost the market for mutation detection kits in the UK.

According to an article published in May 2021, the UK government is changing rules for transgenic plants and animals. This is expected to accelerate research and stimulate investments in the country, supplementing the market’s growth.

Reasons to subscribe to UK mutation detection kits in genome editing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK mutation detection kits in genome editing market databook

  • Our clientele includes a mix of mutation detection kits in genome editing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK mutation detection kits in genome editing market , including forecasts for subscribers. This country databook contains high-level insights into UK mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK mutation detection kits in genome editing market size, by technology, 2017-2028 (US$M)

UK Mutation Detection Kits In Genome Editing Market Outlook Share, 2020 & 2028 (US$M)

UK mutation detection kits in genome editing market size, by technology, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more